Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

43results about How to "Reduce activation" patented technology

Novel nano-drug Res (at) LDH as well as preparation method and application thereof

The invention discloses a novel nano-drug Res (at) LDH and a preparation method and application thereof.Germanium-doped LDH powder and resveratrol are combined to obtain a nanoscale particle mixed material Res (at) LDH, electron paramagnetic resonance (EPR) tests show that both the germanium-doped LDH and the traditional drug resveratrol show excellent reactive oxygen species (ROS) removal characteristics, and the Res (at) LDH can be used for preparing a novel nano-drug Res (at) LDH. The nano-drug Res (at) LDH formed by combining the two has remarkable synergistic ROS removal efficiency which can reach 90%. Meanwhile, in-vivo biological distribution experiments show that the novel nano-drug Res (at) LDH has excellent blood-brain barrier permeability, enhances accumulation in brain tissues, improves neurological dysfunction, reduces infarct volume, shows strong antioxidant activity, and inhibits release of pro-inflammatory cytokines.
Owner:BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Fish feed containing traditional Chinese medicine components for preventing fish enteritis and preparation method of fish feed

The invention discloses a fish feed containing traditional Chinese medicine components for preventing fish enteritis and a preparation method thereof, and belongs to the technical field of fish enteritis prevention. Comprising the following raw materials in parts by weight: 5-8 parts of lactobacillus rhamnosus with the viable count of 1.2 * 10 < 5 >-1.5 * 10 < 5 > CFU / g per gram, 1-2 parts of symbiotic bacillus siamensis LF41 with the viable count of 1.1 * 10 < 5 >-1.2 * 10 < 5 > CFU / g per gram, 30-35 parts of rhein hydrogel and 16-28 parts of a traditional Chinese medicine extract composition, and the traditional Chinese medicine extract comprises the following medicinal materials in parts by weight: 6-10 parts of apple peel polyphenol, 2-5 parts of common wormwood, 3-5 parts of codonopsis pilosula and 5-8 parts of golden cypress. The traditional Chinese medicine extract is coated with the rhein hydrogel. The fish feed containing the traditional Chinese medicine components for preventing the fish enteritis prevents the fish enteritis through a TLR / NF kappa B signal channel, plays a role in targeting intestinal tracts after being eaten by fishes, and is good in drug effect.
Owner:HUIZHOU RENHE AGRICULTURAL TECHNOLOGY CO LTD

Preparation method of composite spray for improving hemostatic capacity of wound part

The invention discloses a preparation method of a composite spray for improving the hemostatic ability of a wound part, the composite spray comprises a liquid A and a liquid B. The liquid B is a sodium alginate aqueous solution, a preparation method of the solution A comprises the following steps: 1, dissolving a lipopeptide conjugate, cholesterol, distearoyl phosphatidylcholine, distearoyl phosphatidylserine and dimethyl sulfoxide in a chloroform-methanol mixed solution to obtain a mixed system; 2, preparing the mixed system into a precursor solution by utilizing a film hydration method; 3, adding calcium chloride into the precursor solution, and reacting in a dark place to obtain a solution A; a precursor solution is designed according to the function of natural platelets, the function of the precursor solution is equivalent to that of nano platelets, the precursor solution is matched with sodium alginate, adverse effects on a blood coagulation system caused by fibrin degradation, platelet activation capability reduction and the like of a wound part due to blood loss can be relieved in a targeted manner, and the preparation has the advantages of rapid hemostasis, good biological activity, no toxic or side effects and the like. And the wound healing is rapid.
Owner:NORTHWEST UNIV

Preparation method of porous carbon for silicon-carbon negative electrode material

The invention provides a preparation method of porous carbon for a silicon-carbon negative electrode material, and belongs to the field of lithium ion battery negative electrode materials. The preparation method of the porous carbon for the silicon-carbon negative electrode material comprises the following steps: crushing and grading, activating and pore-forming, washing and purifying, and carbonizing at high temperature. According to the preparation method of the porous carbon for the silicon-carbon negative electrode material, the technical problems that the yield of the porous carbon for the current silicon-carbon negative electrode material is difficult to increase, the activation process is difficult to control, the activation efficiency is low, the activation effect is poor and the metal pollution prevention and control cost is high are solved, and meanwhile, the uniformity of the pore structure of the porous carbon for the silicon-carbon negative electrode material is further improved; the quality of porous carbon is improved; the production efficiency is improved; and the production cost is reduced.
Owner:山东埃尔派粉体科技股份有限公司 +1

Method for treating leucopenia by analyzing effective components in Qiguo Liangbai capsules based on network pharmacology and application of method

The invention discloses a method for treating leucopenia by analyzing active ingredients of a Qigui Shengbai capsule based on network pharmacology and application of the method. According to the method, main effective components of the Qiguo Liangbai capsule are identified firstly, potential targets and mechanisms of the Qiguo Liangbai capsule are further predicted, and a component-target-signal channel network diagram of the Qiguo Liangbai capsule is constructed by combining network pharmacological analysis of transcriptome and metabonomics; and molecular biology is utilized to verify the component-target-signal path network diagram, and a theoretical basis is further provided for clinical application of the Qigui Liangbai capsule to treatment of leucopenia.
Owner:GUIZHOU HANFANG XIFENG PHARM CO LTD

Application of asparaginase in preparation of medicine for treating pancreatic cancer

PendingCN119524113Apromote apoptosisReduce activationOrganic active ingredientsPeptide/protein ingredientsGemcitabine resistancePancreas Cancers
The invention belongs to the technical field of biological medicines, and particularly relates to application of asparaginase in preparation of a medicine for treating pancreatic cancer. The asparaginase and the gemcitabine are combined for treating pancreatic cancer, and results show that the combination of the two medicines can promote apoptosis of pancreatic cancer cells, reduce proliferation and reduce activation of pancreatic stellate cells, so that an important scientific basis is provided for improving gemcitabine drug resistance, and meanwhile, a new application is provided for the asparaginase.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Method for improving double-reverse flotation froth of silicon-calcium collophanite

The invention belongs to the technical field of phosphorite beneficiation, and particularly discloses a method for improving silicon-calcium collophanite double-reverse flotation froth, which comprises the following steps: adjusting the pH value of phosphorite pulp to be acidic by using oxalic acid, adding a magnesium removal collecting agent for reverse flotation magnesium removal to obtain magnesium-removed concentrate pulp, adding activated carbon into the magnesium-removed concentrate pulp, uniformly mixing, diluting the ore pulp, adjusting the pH value to be 6.5-8, and filtering to obtain the silicon-calcium collophanite double-reverse flotation froth. Adding the foam-inhibiting agent and uniformly mixing; and a cation collecting agent is added for dealumination and desiliconization reverse flotation, and ore pulp obtained after reverse flotation is subjected to solid-liquid separation, so that phosphate concentrate is obtained. According to the method provided by the invention, the pH is adjusted by adopting oxalic acid during reverse flotation magnesium removal, activated carbon is added into ore pulp after magnesium removal to mix an adsorption agent, and a foam inhibition agent is added; the physical and chemical properties of the surface of the foam can be changed, the half-life period of the foam is greatly shortened, and the beneficiation effect is ensured.
Owner:HUBEI XINGFA CHEM GRP CO LTD

Blinarin targeted slow-release nano drug-loading system as well as preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly relates to a linarin targeted slow-release nano drug-loading system as well as a preparation method and application thereof. A polylactic acid-polyglycolic acid copolymer is used as a matrix, polyvinyl alcohol is used as a cross-linking agent, and coated drug-loaded microspheres are formed through cross-linking and grafting of the matrix and the cross-linking agent; and then chitosan is used as a protective agent, chitosan and the coated drug-loaded microspheres are crosslinked and grafted to form double-coated composite drug-loaded microspheres, the chitosan in the composite drug-loaded microspheres is used as a shell, the coated drug-loaded microspheres are used as a core, and the linarin targeted slow-release nano drug-loaded system is obtained. Through the double-target design, the targeting property to cornea and lacrimal gland is enhanced, the treatment efficiency of the medicine is improved, stable release and continuous release of linarin are realized, and the problem of unstable release of the medicine is solved; in addition, the targeted slow-release nano drug-loading system is combined with the anti-inflammatory activity and the mitochondrial protection function of linarin, so that the side effects on eyes are reduced, and the safety is improved.
Owner:HUNAN UNIV OF CHINESE MEDICINE

Transmission method and device, terminal and network equipment

PendingCN119602918Ashorten activation timeReduce activationTransmission path divisionRadio transmissionComputer networkEngineering
The invention provides a transmission method and device, a terminal and network equipment. The method comprises the following steps: after a cell activation command, sending a first report to a network; and / or sending first information to a network, the first information being related to the beam; and / or determining a first time, the first time being related to cell activation. By adopting the transmission method provided by the embodiment of the invention, the terminal sends the first report to the network after the cell activation command, and the terminal sends the first information to the network and / or determines the first time, thereby achieving the effect of reducing the activation delay of the secondary cell.
Owner:CHINA MOBILE COMM LTD RES INST +1

Use of melanin in preparing medicine for treating chronic ulcerative colitis and its associated depressive-like behavior

The present invention relates to the field of biomedicine technology, and discloses a use of melanin in the preparation of a drug for treating chronic ulcerative colitis and its associated depressive-like behavior. The present invention is the first to discover that melanin has the efficacy of treating chronic ulcerative colitis and its associated depressive-like behavior. MSPI can inhibit the LPS / TLR4 / NLRP3 / ASC / Caspase‑1 inflammatory signaling pathway, reduce oxidative stress, and restore the intestinal barrier, thereby improving UC symptoms. In addition, MSPI can also reduce glial cell activation, brain neuroinflammatory response and neuronal apoptosis, thereby reducing depressive-like behavior.
Owner:QINGDAO UNIV OF SCI & TECH +1

Sprayable dual-network hydrogel microsphere adhesive, method of making and use thereof

ActiveCN121154893BAdhesivelyImprove mechanical properties
The application belongs to the technical field of biological medicine, and specifically discloses a sprayable double-network hydrogel microsphere adhesive as well as a preparation method and application thereof. The preparation method comprises the following steps: liquid paraffin and sorbitan monooleate, polyoxyethylene sorbitan monolaurate are taken as oil phases to form an emulsion; the emulsion is fully mixed with petroleum ether, centrifugal separation is performed on the gel hydrogel microspheres, and freeze-drying is performed on the gel hydrogel microspheres for storage in the dark; preparation of ropivacaine liposomes; ultrapure water is added into the lipid membrane to obtain a primary liposome suspension, the hydrogel microspheres are used to adsorb the liposomes, and the obtained double-network hydrogel microspheres are collected. The sprayable double-network hydrogel microsphere adhesive as well as the preparation method and application thereof can be used to prepare hydrogel microspheres which can quickly and uniformly cover irregular wounds, and the liposomes carrying ropivacaine can provide sustained analgesic release, so that the problems of maintaining sustained adhesion in a blood-saturated wound and prolonging pain relief are simultaneously solved.
Owner:ZHEJIANG CANCER HOSPITAL +1

Use of timolol in the preparation of a medicament for the prevention and / or treatment of liver fibrosis

PendingCN122499150ASignificant effectExcellent anti-fibrosis effect
The application discloses application of tamibarotene in preparation of a medicine for preventing and / or treating liver fibrosis, and belongs to the technical field of biological medicine. The application finds that tamibarotene has a significant anti-liver fibrosis effect for the first time. Experimental results show that in two kinds of liver fibrosis animal models induced by CCl4 and TAA, tamibarotene can significantly down-regulate the expression of alpha-SMA and type I collagen, reduce the liver inflammatory response, and improve liver function. In particular, the anti-fibrosis effect of tamibarotene is significantly better than that of RARbeta selective agonist KCL-286 and RARalpha selective agonist Am580, and an unexpected technical effect is achieved. The application provides a new medicine selection for the treatment of liver fibrosis, and has a good clinical application prospect and development value.
Owner:南昌大学第一附属医院

Application of FCN2 as target spot in screening or treating Alzheimer's disease

The invention relates to the technical field of medical biological detection, provides a new application of FCN2, particularly relates to an application of FCN2 as a target spot in screening or treating Alzheimer's disease, and further provides a kit for performing early screening or curative effect evaluation on Alzheimer's disease by utilizing quantitative detection aiming at FCN2 and a medicine taking the kit as the target spot. The kit and the detection method disclosed by the invention are simple, convenient, reliable, short in period, high in specificity and easy to clinically popularize. The liver-derived plasma protein Ficolin-2 (FCN2) can be used as an early screening target and a drug treatment target of the Alzheimer's disease (AD), is particularly used as a kit and other medical equipment products to be applied, and has important significance on early discovery, precise treatment, curative effect monitoring and the like of high-risk patients.
Owner:SHANGHAI FOURTH PEOPLES HOSPITAL

2-Heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer

InactiveMA47447AInhibition of activationReduce activation
The present invention relates to 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamide compounds of general formula (i), wherein x, r1, r2, r3, r4, and r5 are as defined in the description. The invention also relates to methods for preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular cancer or diseases with dysregulation of immune responses or other disorders associated with aberrant AHR signals, as monotherapy or in combination with other active ingredients.
Owner:BAYER PHARMA AG +2

Optimal path planning method of pulse coupling neural network based on double constraints

PendingCN121954041Aguaranteed optimalityReduce activationInstruments for road network navigationPathPingAlgorithm
The invention discloses an optimal path planning method of a pulse coupling neural network based on double constraints. The method comprises the following steps: mapping a path planning environment to a DC-PCNN network; a DC-PCNN neural network model is constructed, and all neurons are initialized; activating a target neuron, and recording the current neuron as a father node; calculating an exponential decay function of the torque deviation, and multiplying the calculated value as a penalty factor by an update item of the internal activity item; calculating a gravitational function value of the flow field constraint, and using the calculated value to update a current neuron dynamic threshold value; comparing the internal activity item with a dynamic threshold; when gt; if yes, activating the neuron, and recording the current neuron as a father node; repeating the steps S4-S6 until the initial neuron is activated; and backtracking all activated nodes, and planning an optimal path. According to the method, the search efficiency is remarkably improved while the path optimality is ensured.
Owner:NORTHWEST UNIVERSITY FOR NATIONALITIES

Preparation method of multifunctional cuprous oxide-based nano composite antibacterial material

The invention discloses a preparation method of a multifunctional cuprous oxide-based nano-composite antibacterial material, which comprises the following steps: adding a copper salt and a proper amount of deionized water into a reaction kettle, heating to 45-60 DEG C, uniformly stirring, adding a surfactant, slowly dropwise adding a pH regulator until the pH is 9-10, reacting for 2-3 hours, adding a reducing agent until the precipitate becomes brick red, filtering, washing, and drying to obtain the cuprous oxide-based nano-composite antibacterial material. Adding a zinc salt, a titanium salt, a silver salt, a platinum salt, a cerium salt and a lanthanum salt, adding a pH regulator until the pH value is 9-10, continuously stirring for 60-90 minutes, standing, filtering out water, and drying the precipitate to obtain the multifunctional cuprous oxide-based nano composite antibacterial material. The method disclosed by the invention is simple in process, the reaction process is easy to control, and the prepared cuprous oxide-based nano composite antibacterial material has excellent multiple effects of rapid sterilization, lasting bacteriostasis, mildew prevention, virus resistance, formaldehyde removal, odor removal, wastewater and sewage degradation and the like.
Owner:EAST CHINA JIAOTONG UNIVERSITY +1

Modified montmorillonite nanosheet capable of being used as cfDNA scavenger as well as preparation method and application of modified montmorillonite nanosheet

The invention discloses a modified montmorillonite nanosheet capable of being used as a cfDNA scavenger as well as a preparation method and application of the modified montmorillonite nanosheet. The modified nanosheet is prepared by modifying the surface of a two-dimensional montmorillonite nanosheet with polylysine cations. The modified montmorillonite nanosheet can achieve the effect of inhibiting inflammation by removing cfDNA and adjusting the abundance of intestinal microorganisms, effectively relieves symptoms induced by IBD, has good stability, biocompatibility and biodegradability, and can be used for treating inflammatory bowel diseases.
Owner:HEFEI UNIV OF TECH

Mannan-binding lectin modified protein ppg-rep-MBL, DNA molecule, expression vector, host cell and application

The invention relates to mannan-binding lectin modified protein ppg-rep-MBL, a DNA (deoxyribonucleic acid) molecule, an expression vector, a host cell and application, and belongs to the technical field of biological medicine. The invention provides mannan-binding lectin modified protein ppg-rep-MBL, the amino acid sequence of the mannan-binding lectin modified protein ppg-rep-MBL is shown as SEQ ID NO: 3, and the nucleotide sequence of the mannan-binding lectin modified protein ppg-rep-MBL is shown as SEQ ID NO: 4. The invention also provides an application of the mannan binding lectin modified protein ppg-rep-MBL in preparation of a medicine for preventing or / and treating coronavirus infection. The modified protein is not combined with MASP2 protein, so that the activation effect on a complement agglutinin pathway is obviously weakened, meanwhile, the combination characteristic of the modified protein and mannose is reserved, and the modified protein can be effectively combined with and block infection of a novel coronavirus pseudovirus and a Delta mutant strain thereof on HEK293T-ACE2 cell; a candidate possibility is provided for designing the protein into a broad-spectrum anti-coronavirus infection inhibitor or a drug.
Owner:SICHUAN UNIV

Sodium difluorophosphate as well as preparation method and application thereof

The invention relates to the technical field of sodium ion battery electrolytes, in particular to sodium difluorophosphate and a preparation method and application thereof.The preparation method comprises the following steps that sodium hexafluorophosphate and oxide react in a non-aqueous solvent, solid-liquid separation is conducted on a product obtained after the reaction is finished, then reduced pressure distillation is conducted on filtrate, and sodium difluorophosphate is obtained; the preparation method comprises the following steps: adding sodium difluorophosphate into a reaction kettle, carrying out suction filtration after carrying out cold shock by using a non-aqueous solvent, filtering out mother liquor, washing the product by using absolute ether, and drying the obtained product to obtain white powdery sodium difluorophosphate. According to the preparation method of the sodium difluorophosphate, the reaction process is one-step reaction, the reaction does not need toxic gases such as HF, the preparation process is convenient, rapid and easy to operate, more inorganic salts can be dissolved by selecting the polar solvent, so that the reaction is more sufficient, byproducts are easy to separate, impurities are prevented from being introduced, the product purity is higher, and the method is suitable for industrial production. And the liquid product obtained after the one-step reaction can be used as the electrolyte of the sodium-ion battery after being processed, so that a direction is provided for the application of the sodium-ion battery.
Owner:LANZHOU UNIVERSITY OF TECHNOLOGY

Application of Cpd1 in preparation of medicine or combined medicine for treating diabetic retinopathy

The invention discloses an application of Cpd1 in preparation of a medicine or a combined medicine for treating diabetic retinopathy, the agonist Cpd1 of GPR61 increases the retinal thickness of a mouse with diabetic retinopathy and reduces formation of microaneurysm, and the Cpd1 reduces activation and proliferation of retinal Muller cells induced by high glucose and release of proinflammatory cytokines, so that the effect of treating diabetic retinopathy is achieved. Compared with the existing anti-VEGF drug therapy, the Cpd 1 does not need to be injected repeatedly, so that the economic burden of NPDR patients and the trouble of re-diagnosis are reduced.
Owner:NANTONG UNIV

Silicone grease nanoparticles loaded with SHAP oligopeptide as well as preparation method and application of silicone grease nanoparticles

The invention provides a silicone grease nano-particle loaded with SHAP oligopeptide as well as a preparation method and application of the silicone grease nano-particle. According to the application disclosed by the invention, turbulence stimulation of human umbilical vein endothelial cells is simulated by virtue of treatment of oscillation shearing force, and immunofluorescence, immunoblotting, THP1 adhesion experiments and the like are used for the first time, so that the situation that the SHAP oligopeptide cannot play an obvious role independently is found, while the SHAP oligopeptide can effectively protect the phosphorylation level of MST1 / 2 in HUVECs caused by turbulence stimulation after being loaded in silicon lipid (SLS), so that the SHAP oligopeptide can be used for preparing the HUVECs. Therefore, the activation of endothelial cells is reduced. Furthermore, the invention innovatively discovers and verifies the treatment effect of the silicone grease nanoparticles loaded with the SHAP oligopeptide on the atherosclerosis. In conclusion, the silicone grease nanoparticles loaded with the SHAP oligopeptide, provided by the invention, provide a new thought for relieving and treating the atherosclerosis.
Owner:TIANJIN MEDICAL UNIV

Roxburgh rose extract capable of improving inflammation level of sepsis and preparation method of roxburgh rose extract

PendingCN119113002AImprove biochemical indicatorsreduce formationAntipyreticAnalgesicsBiotechnologyPharmaceutical drug
The invention belongs to the technical field of plant extraction, and discloses a roxburgh rose extract capable of improving the sepsis inflammation level and a preparation method thereof.The process comprises the steps of raw material treatment, freezing, drying, auxiliary material mixing, extraction, concentration and drying.The roxburgh rose extract capable of improving the sepsis inflammation level and the preparation method of the roxburgh rose extract capable of improving the sepsis inflammation level are provided; the obtained food-grade extract can be used for recovery and improvement of sepsis, and the roxburgh rose extract reduces the inflammation level of sepsis and alleviates organ injury by a multi-path combined regulation mechanism. The invention provides a safe and effective new means for the existing method for treating sepsis by drugs, supplements and perfects the preparation technology, functional activity and active action mechanism of the roxburgh rose extract, expands the application limitation of roxburgh rose in the clinical medicine field, and has a good application prospect by applying the roxburgh rose extract to sepsis intervention. The method is suitable for preparing the rosa roxburghii tratt extract, and the prepared rosa roxburghii tratt extract is suitable for adjuvant therapy of sepsis.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

A collagen anti-corrosion coating with tissue repair properties, its preparation method and applications

This invention discloses a collagen-based anti-corrosion coating with tissue repair properties, its preparation method, and its applications, belonging to the field of medical coating technology. This invention designs a novel self-healing anti-corrosion coating and loads collagen onto the coating using excipients, achieving a deep integration of anti-corrosion protection and biological function. The prepared collagen-based anti-corrosion coating is firmly bonded to a magnesium alloy substrate via covalent bonds. After 4 weeks of in vivo implantation, no cracking or detachment was observed, the stent structure maintained good integrity, and it provides continuous radial support, offering sufficient time for vascular repair. This provides a feasible solution for the clinical translation of next-generation biodegradable magnesium-based vascular stents.
Owner:SICHUAN UNIV

Hollow fiber hemodialysis membrane based on in-situ self-assembly and preparation method thereof

PendingCN121846915Aprocess stabilitySolve the fundamental problem of easy loss due to low bonding strengthSemi-permeable membranesDialysis systemsDialysis membranesHollow fibre
The invention discloses a hollow fiber hemodialysis membrane based on in-situ self-assembly and a preparation method thereof. According to the membrane, PES is used as a matrix, PES, PVP and SF are co-dissolved in a N, N-dimethylacetamide DMAc solvent according to a specific proportion, and dry-wet spinning and an accurate non-solvent induced phase separation regulation technology are adopted, so that the silk fibroin and PVP have a synergistic effect in the phase inversion process, and the membrane is prepared. And multi-stage microphase separation and self-assembly are carried out, so that in-situ and lasting anchoring on the membrane substrate and the surface is realized. The dialysis membrane prepared by the method has excellent long-acting pollution resistance, excellent blood compatibility and a stable three-dimensional gradient structure. The invention further provides an intelligent response type expansion scheme of the membrane, and the membrane can dynamically adjust the performance according to the physiological state of a patient by introducing an environment response component, so that individualized precise dialysis is realized.
Owner:CHENGDU MEMBRANE BIOTECHNOLOGY CO LTD

A viscosity and glycosidase dual-locked fluorescent probe, and a preparation method and application thereof

PendingCN122255200AEnhanced fluorescence emission intensityFluorescence emission intensity increases due to increasedSugar derivativesMicrobiological testing/measurementFluoProbesChemical compound
The present application relates to the technical field of fluorescent probe, and discloses a fluorescent probe locked by viscosity and glycosidase, and a preparation method and application thereof.The present application provides a compound, the fluorescence emission intensity of which is enhanced with the enhancement of the solution viscosity; meanwhile, after incubation with beta-galactosidase, the fluorescence intensity of the compound at 640nm is enhanced.Therefore, in the early diagnosis imaging of ovarian cancer, the compound can be used as a fluorescent probe locked by viscosity and glycosidase, and is used for accurate imaging of ovarian cancer.The fluorescent probe of the present application greatly improves the selectivity of the probe by using a double activation mechanism, effectively avoids non-specific activation to normal tissues, and is particularly suitable for targeted imaging of specific pathological environments such as tumors.
Owner:亳州优开生物医药科技有限公司

Non-contact temperature control method and system for small animal experiment

The invention discloses a non-contact temperature control method and system for a small animal experiment, and belongs to the technical field of experimental animal temperature control. The temperature control method comprises the following steps: S01, fixing an experimental small animal; s02, setting a preset temperature, and carrying out non-contact heating on the target area by adopting a laser heating unit; s03, an infrared temperature measurement unit is adopted to accurately detect the temperature of the target area, the temperature detected in real time is fed back to a control system unit, and the control system unit compares temperature differences; the control system regulates and controls the output power of the laser heating unit; and S04, when the real-time detection temperature of the infrared temperature measurement unit is equal to the preset temperature, non-contact temperature control is completed. According to the invention, non-contact heating of the laser heating unit is adopted; real-time monitoring temperature feedback of the infrared temperature measuring unit is received through the control system unit, accurate heating is performed step by step in a heating mode, accurate control over non-contact temperature control is achieved, and the temperature control accuracy error is within 0.1 DEG C.
Owner:INST OF ACUPUNCTURE & MOXIBUSTION CHINA ACADEMY OF CHINESE MEDICAL SCI

Application of Sema3E inhibitor in preparation of medicine for preventing, delaying or treating COPD small airway fibrosis

The invention belongs to the technical field of biological medicines, discloses an application of a Sema3E inhibitor in preparation of a medicine for preventing, delaying or treating COPD small airway fibrosis, and proposes that the Sema3E inhibitor can be used for treating, preventing or delaying the COPD small airway fibrosis for the first time. The Sema3E inhibitor plays a role by inhibiting the expression of Sema3E. The specific molecular mechanism is as follows: by inhibiting the expression of Sema3E, inhibiting the expression of Wnt5a / b, beta-Catenin, increasing the expression of p-beta-Catenin, inhibiting the activation of a Wnt / beta-Catenin pathway, and inhibiting the activation / proliferation / migration of small airway fibroblasts. Through the mechanism, the effect of preventing, delaying or treating the COPD is achieved, and a new drug intervention target, namely Sema3E, is provided for treatment of the COPD.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Method for isolating target cells

The present invention relates to a method for isolating viable target cells from a sample as well as a cartridge, a kit, a device and a drug comprising viable target cells obtainable by said method configured for use in said method, the method comprises the step of contacting a sample comprising a suspension of viable target cells, the viable target cells exhibiting molecules on the cell surface, with non-porous microparticles having a density of about 1.45 g / cm3 or greater, a diameter of about 10 [mu] m to 200 [mu] m, and capture ligands covalently immobilized to the surface of the microparticles, the capture ligand is capable of specifically binding to the molecule; incubating the sample without substantially stirring to form a target cell / microparticle complex; separating the target cell / particle complex from the unbound species in the sample by washing the unbound species through a filter while retaining the target cell / particle complex; the target cell / microparticle complex is mechanically dissociated and the viable target cells are eluted through the filter while retaining the microparticles with the capture ligands covalently immobilized to the surface of the microparticles.
Owner:BIO RECELL LTD

Artemisia apiacea-containing permeation-promoting composition with skin cell repairing and relieving effects, and preparation method and application thereof

ActiveCN121971347Areduce recruitmentreduce infiltrationCosmetic preparationsAntipyreticAvena sativa KernelCell recruitment
The invention relates to an artemisia apiacea-containing penetration enhancing composition with skin cell repairing and relieving effects, and a preparation method and application thereof, and belongs to the technical field of cosmetics. The research finds that the anti-inflammatory effect generated by only inhibiting an upstream anti-inflammatory path of an NF-kappa B channel is limited, and the anti-inflammatory effect can be remarkably enhanced by blocking a downstream conduction chain while inhibiting the NF-kappa B channel. On the basis, through the artemisia apiacea extract and the flos magnoliae extract, an upstream anti-inflammatory path is inhibited, recruitment and infiltration of inflammatory cells are reduced, a downstream conduction chain is blocked, and the anti-inflammatory effect is synergistically improved. Besides, through cooperation of the oat kernel oil, the jasmine flower oil and the squalane, on one hand, the solubility of fat-soluble active matter is improved, on the other hand, the composition can participate in repairing, stabilizing and optimizing the lipid structure of the skin cuticle, synchronously open the skin fat-soluble channel and convey the active matter more efficiently, and therefore the excellent relieving, repairing and stabilizing effects are achieved.
Owner:SHANGHAI FOREST CABIN BIOLOGICAL-TECH CO LTD

Rabies virus circular RNA vaccine as well as preparation and application thereof

The invention relates to a rabies virus vaccine, in particular to a rabies virus circular RNA (Ribonucleic Acid) vaccine as well as preparation and application thereof. The rabies virus CircRNA vaccine comprises CircRNA and a vaccine vector, wherein the CircRNA is used for expressing optimized rabies virus immunogen. The rabies virus CircRNA vaccine is prepared, and the stability and the protein expression efficiency of the optimized sequence are remarkably improved at the same time. The vaccine can rapidly induce high-level anti-rabies virus immune response, and has no obvious toxic or side effect. According to the rabies inactivated vaccine, the immunizing frequency of the existing rabies inactivated vaccine can be reduced, the problems of virus pollution and the like are not involved, and the rabies inactivated vaccine is more economical, safer and more efficient.
Owner:CHINA PHARM UNIV